טוען...
COVID-19 Associated Hypercoagulability: Manifestations, Mechanisms, and Management
Patients with severe coronavirus disease-2019 (COVID-19) frequently have hypercoagulability caused by the immune response to the severe acute respiratory syndrome coronavirus-2 infection. The pathophysiology of COVID-19 associated hypercoagulability is not fully understood, but characteristic change...
שמור ב:
| הוצא לאור ב: | Shock |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Lippincott Williams & Wilkins
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7959868/ https://ncbi.nlm.nih.gov/pubmed/32890309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/SHK.0000000000001660 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|